Darifenacin 13668-0203-05
- Manufacturer
- Torrent Pharmaceuticals Limited
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 18, 2016
- Listing Expires
- December 31, 2027
- Application
- ANDA205209
Need to source Darifenacin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Darifenacin Hydrobromide | 15 mg/1 |
Drug Class
Cholinergic Muscarinic Antagonist [EPC]Cholinergic Muscarinic Antagonists [MoA]
Selected Package
13668-0203-05Selected500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-203-05)
Other packages for this product(2)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-203-30)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-203-90)